Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotox'c effects of organ'c solvent exposure

Clinical Toxicology

Volumn 51, Issue 8, 2013, Pages 748-751

  Züngün, Cevdet ^a   Yilmaz, Fatma Meriã ^a,b   Tutkun, Engin ^c   Yilmaz, Hinã ^c   Uysal, Sema ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ANKARA OCCUPATIONAL DISEASES HOSPITAL   (Turkey)

Author keywords

Neurotoxicity; NSE; Organic solvent; Oxidative stress; S100B

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; METHANOL; NEURON SPECIFIC ENOLASE; ORGANIC SOLVENT; PROTEIN S100B; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ADULT; AGED; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ESTERIFICATION; FEMALE; HEADACHE; HUMAN; LABORATORY TEST; MALE; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; PARESTHESIA; URINALYSIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GAS; ELECTROCHEMICAL TECHNIQUES; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROTOXICITY SYNDROMES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PHOSPHOPYRUVATE HYDRATASE; REACTIVE OXYGEN SPECIES; S100 PROTEINS; SOLVENTS; TRICHLOROACETIC ACID; TRICHLOROETHYLENE; YOUNG ADULT;

EID: 84884652911     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.820831     Document Type: Article

References (24)

1. Lash LH, Fisher JW, Lipscomb JC, Parker JC. Metabolism of trichloroethylene. Environ Health Perspect 2000; 108: 177-200. (Pubitemid 30420979)
2. Bast-Pettersen R. The neuropsychological diagnosis of chronic solvent induced encephalopathy (CSE)-a reanalysis of neuropsychological test results in a group of CSE patients diagnosed 20 years ago, based on comparisons with matched controls. Neurotoxicology. 2009; 30: 1195-1201.
3. Verberk MM, van der Hoek JA, van Valen E, Wekking EM, van Hout MS, Hageman G, et al. Decision rules for assessment of chronic solvent-induced encephalopathy: results in 2370 patients. Neurotoxicology 2012; 33: 742-52.
4. Chalansonnet M, Carabin N, Boucard S, Cosnier F, Nunge H, Gagnaire F. Study of the potential oxidative stress induced by six solvents in the rat brain. Neurotoxicology 2012; 35C: 71-83.
5. Ni YC, Wong TY, Lloyd RV, Heinze TM, Shelton S, Casciano D, et al. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab Dispos 1996; 24: 81-90. (Pubitemid 26028386)
6. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2004; 44: 27-42. (Pubitemid 38263832)
7. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004; 72: 111-27. (Pubitemid 38519589)
8. Hamed SA, Hamed EA, Zakary MM. Oxidative stress and S-100B protein in children with bacterial meningitis. BMC Neurol 2009; 9: 51.
9. van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC. Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 2009; 9: 21.
10. NIOSH Pocket Guide To Chemical Hazards. DHHS (NIOSH) Publication No. 2005-149.
11. Ohara A, Michitsuji H, Jyoyama Y, Yamaguchi K, Fujiki Y. [Determination of trichloroacetic acid and trichloroethanol by head-space gas chromatography (HS.GC)]. Sangyo Igaku 1991; 33: 94-103.
12. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein s-100b and glial fibrillary acidic protein. Stroke 2000; 31: 2670-2677.
13. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003; 60: 614-632.
14. Papandreou O, Soldatou A, Tsitsika A, Kariyannis C, Papandreou T, Zachariadi A, et al. Serum S100beta protein in children with acute recurrent headache: a potentially useful marker for migraine. Headache 2005; 45: 1313-1316. (Pubitemid 350004944)
15. Yilmaz N, Karaali K, Ozdem S, Turkay M, Unal A, Dora B. Elevated S100B and neuron specific enolase levels in patients with migrainewithout aura: evidence for neurodegeneration? Cell Mol Neurobiol 2011; 31: 579-585.
16. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
17. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695. (Pubitemid 23350687)
18. Olanow C W. A radical hypothesis for neurodegeneration. Trends Neurosci 1993; 16: 439-444. (Pubitemid 23313517)
19. Kyrklund T, Goracci G, Haglid KG, Rosengren L, Porcellati G, Kjellstrand P. Chronic effects of trichloroethylene upon S-100 protein content and lipid composition in gerbil cerebellum. Scand J Work Environ Health 1984; 10: 89-93. (Pubitemid 14123828)
20. Rosengren LE, Kjellstrand P, Aurell A, Haglid KG. Irreversible effects of dichloromethane on the brain after long term exposure: a quantitative study of DNA and the glial cell marker proteins S-100 and GFA. Br J Ind Med 1986; 43: 291-299. (Pubitemid 16071632)
21. B arger S W, V an Eldik L J, M attson M P. S 100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res 1995; 677: 167-170.
22. Fogel W, Krieger D, Veith M, Adams HP, Hund E, Storch-Hagenlocher B, et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997; 25: 1133-1138. (Pubitemid 27310251)
23. Herrmann M, Ebert AD, Galazky I, Wunderlich MT, Kunz WS, Huth C. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke 2000; 31: 645-650. (Pubitemid 30131649)
24. CDC. Organic solvent neurotoxicity. National Institute for Occupational Safety and Health (NIOSH). 1987; Current Intelligence Bulletin 48